title: Contact dermatitis due to levobunolol in eyedrops.
authors.affiliation: Seccion de Alergología, Hospital General Yagüe, Burgos, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Garcia
authors.forename: J
authors.initials: J
authors.lastname: Blanco
authors.forename: S
authors.initials: S
authors.lastname: Juste
authors.forename: M M
authors.initials: MM
authors.lastname: Garces
authors.forename: L
authors.initials: L
authors.lastname: Alonso
authors.forename: M L
authors.initials: ML
authors.lastname: Marcos
authors.forename: P
authors.initials: P
authors.lastname: Carretero
authors.forename: R
authors.initials: R
authors.lastname: Perez
mesh_terms: D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000209:etiology*; D005143:Eyelids; D005260:Female; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D002040:Levobunolol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D009883:Ophthalmic Solutions / Q000009:adverse effects*; D010328:Patch Tests
chemical_list: D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D002040:Levobunolol